91 related articles for article (PubMed ID: 23533157)
1. Tumorigenic potential of miR-18A* in glioma initiating cells requires NOTCH-1 signaling.
Turchi L; Debruyne DN; Almairac F; Virolle V; Fareh M; Neirijnck Y; Burel-Vandenbos F; Paquis P; Junier MP; Van Obberghen-Schilling E; Chneiweiss H; Virolle T
Stem Cells; 2013 Jul; 31(7):1252-65. PubMed ID: 23533157
[TBL] [Abstract][Full Text] [Related]
2. Notch1 signaling pathway promotes invasion, self-renewal and growth of glioma initiating cells via modulating chemokine system CXCL12/CXCR4.
Yi L; Zhou X; Li T; Liu P; Hai L; Tong L; Ma H; Tao Z; Xie Y; Zhang C; Yu S; Yang X
J Exp Clin Cancer Res; 2019 Aug; 38(1):339. PubMed ID: 31382985
[TBL] [Abstract][Full Text] [Related]
3. miR-33a promotes glioma-initiating cell self-renewal via PKA and NOTCH pathways.
Wang H; Sun T; Hu J; Zhang R; Rao Y; Wang S; Chen R; McLendon RE; Friedman AH; Keir ST; Bigner DD; Li QJ; Wang H; Wang XF
J Clin Invest; 2014 Oct; 124(10):4489-502. PubMed ID: 25202981
[TBL] [Abstract][Full Text] [Related]
4. miR-92a-3p Exerts Various Effects in Glioma and Glioma Stem-Like Cells Specifically Targeting CDH1/β-Catenin and Notch-1/Akt Signaling Pathways.
Song H; Zhang Y; Liu N; Zhao S; Kong Y; Yuan L
Int J Mol Sci; 2016 Oct; 17(11):. PubMed ID: 27801803
[TBL] [Abstract][Full Text] [Related]
5. The miR 302-367 cluster drastically affects self-renewal and infiltration properties of glioma-initiating cells through CXCR4 repression and consequent disruption of the SHH-GLI-NANOG network.
Fareh M; Turchi L; Virolle V; Debruyne D; Almairac F; de-la-Forest Divonne S; Paquis P; Preynat-Seauve O; Krause KH; Chneiweiss H; Virolle T
Cell Death Differ; 2012 Feb; 19(2):232-44. PubMed ID: 21720384
[TBL] [Abstract][Full Text] [Related]
6. AURKA governs self-renewal capacity in glioma-initiating cells via stabilization/activation of β-catenin/Wnt signaling.
Xia Z; Wei P; Zhang H; Ding Z; Yang L; Huang Z; Zhang N
Mol Cancer Res; 2013 Sep; 11(9):1101-11. PubMed ID: 23761169
[TBL] [Abstract][Full Text] [Related]
7. Paired related homeobox 1 transactivates dopamine D2 receptor to maintain propagation and tumorigenicity of glioma-initiating cells.
Li Y; Wang W; Wang F; Wu Q; Li W; Zhong X; Tian K; Zeng T; Gao L; Liu Y; Li S; Jiang X; Du G; Zhou Y
J Mol Cell Biol; 2017 Aug; 9(4):302-314. PubMed ID: 28486630
[TBL] [Abstract][Full Text] [Related]
8. Notch inhibition by the ligand DELTA-LIKE 3 defines the mechanism of abnormal vertebral segmentation in spondylocostal dysostosis.
Chapman G; Sparrow DB; Kremmer E; Dunwoodie SL
Hum Mol Genet; 2011 Mar; 20(5):905-16. PubMed ID: 21147753
[TBL] [Abstract][Full Text] [Related]
9. Actin cytoskeleton regulator Arp2/3 complex is required for DLL1 activating Notch1 signaling to maintain the stem cell phenotype of glioma initiating cells.
Zhang C; Hai L; Zhu M; Yu S; Li T; Lin Y; Liu B; Zhou X; Chen L; Zhao P; Zhou H; Huang Y; Zhang K; Ren B; Yang X
Oncotarget; 2017 May; 8(20):33353-33364. PubMed ID: 28380416
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-218 inhibits glioma invasion, migration, proliferation, and cancer stem-like cell self-renewal by targeting the polycomb group gene Bmi1.
Tu Y; Gao X; Li G; Fu H; Cui D; Liu H; Jin W; Zhang Y
Cancer Res; 2013 Oct; 73(19):6046-55. PubMed ID: 23950210
[TBL] [Abstract][Full Text] [Related]
11. Autophagy suppresses self-renewal ability and tumorigenicity of glioma-initiating cells and promotes Notch1 degradation.
Tao Z; Li T; Ma H; Yang Y; Zhang C; Hai L; Liu P; Yuan F; Li J; Yi L; Tong L; Wang Y; Xie Y; Ming H; Yu S; Yang X
Cell Death Dis; 2018 Oct; 9(11):1063. PubMed ID: 30337536
[TBL] [Abstract][Full Text] [Related]
12. Notch-mediated repression of miR-223 contributes to IGF1R regulation in T-ALL.
Gusscott S; Kuchenbauer F; Humphries RK; Weng AP
Leuk Res; 2012 Jul; 36(7):905-11. PubMed ID: 22424712
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal stem cells modified with miR-126 release angiogenic factors and activate Notch ligand Delta-like-4, enhancing ischemic angiogenesis and cell survival.
Huang F; Zhu X; Hu XQ; Fang ZF; Tang L; Lu XL; Zhou SH
Int J Mol Med; 2013 Feb; 31(2):484-92. PubMed ID: 23229021
[TBL] [Abstract][Full Text] [Related]
14. Notch1 signaling promotes primary melanoma progression by activating mitogen-activated protein kinase/phosphatidylinositol 3-kinase-Akt pathways and up-regulating N-cadherin expression.
Liu ZJ; Xiao M; Balint K; Smalley KS; Brafford P; Qiu R; Pinnix CC; Li X; Herlyn M
Cancer Res; 2006 Apr; 66(8):4182-90. PubMed ID: 16618740
[TBL] [Abstract][Full Text] [Related]
15. miR-143 inhibits glycolysis and depletes stemness of glioblastoma stem-like cells.
Zhao S; Liu H; Liu Y; Wu J; Wang C; Hou X; Chen X; Yang G; Zhao L; Che H; Bi Y; Wang H; Peng F; Ai J
Cancer Lett; 2013 Jun; 333(2):253-60. PubMed ID: 23376635
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-146a inhibits glioma development by targeting Notch1.
Mei J; Bachoo R; Zhang CL
Mol Cell Biol; 2011 Sep; 31(17):3584-92. PubMed ID: 21730286
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of the Hedgehog signaling pathway suppresses cell proliferation by regulating the Gli2/miR-124/AURKA axis in human glioma cells.
Xu L; Liu H; Yan Z; Sun Z; Luo S; Lu Q
Int J Oncol; 2017 May; 50(5):1868-1878. PubMed ID: 28393219
[TBL] [Abstract][Full Text] [Related]
18. Targeting the Notch-regulated non-coding RNA TUG1 for glioma treatment.
Katsushima K; Natsume A; Ohka F; Shinjo K; Hatanaka A; Ichimura N; Sato S; Takahashi S; Kimura H; Totoki Y; Shibata T; Naito M; Kim HJ; Miyata K; Kataoka K; Kondo Y
Nat Commun; 2016 Dec; 7():13616. PubMed ID: 27922002
[TBL] [Abstract][Full Text] [Related]
19. MiR-129 triggers autophagic flux by regulating a novel Notch-1/ E2F7/Beclin-1 axis to impair the viability of human malignant glioma cells.
Chen X; Zhang Y; Shi Y; Lian H; Tu H; Han S; Yin J; Peng B; Zhou B; He X; Liu W
Oncotarget; 2016 Feb; 7(8):9222-35. PubMed ID: 26824182
[TBL] [Abstract][Full Text] [Related]
20. miRNA profiling in colorectal cancer highlights miR-1 involvement in MET-dependent proliferation.
Reid JF; Sokolova V; Zoni E; Lampis A; Pizzamiglio S; Bertan C; Zanutto S; Perrone F; Camerini T; Gallino G; Verderio P; Leo E; Pilotti S; Gariboldi M; Pierotti MA
Mol Cancer Res; 2012 Apr; 10(4):504-15. PubMed ID: 22343615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
